Advanced search
Publication Cover
Cancer Biology & Therapy Volume 24, 2023 - Issue 1
Submit an article Journal homepage
1,716
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Identification of USP29 as a key regulator of nucleotide biosynthesis in neuroblastoma through integrative analysis of multi-omics data

Ye Kanga Department of Cancer Precision Medicine, the MED-X Institute, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaView further author information
,
Yahuan Yub Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, ChinaView further author information
,
Yijia Liuc Precision Medicine Center, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaView further author information
,
Yiwen Panc Precision Medicine Center, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaView further author information
,
Ru Zhanga Department of Cancer Precision Medicine, the MED-X Institute, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaView further author information
,
Doudou Rena Department of Cancer Precision Medicine, the MED-X Institute, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaView further author information
,
Zeqiong Caia Department of Cancer Precision Medicine, the MED-X Institute, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaView further author information
,
Junpeng Mac Precision Medicine Center, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China;d Center for Molecular Diagnosis and Precision Medicine, Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaView further author information
,
Xiaofan Xionge Precision Medicine Institute, Western China Science and Technology Innovation Harbor, Xi’an, ChinaView further author information
,
Qi Zhangf Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaView further author information
,
Chengsheng Zhanga Department of Cancer Precision Medicine, the MED-X Institute, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China;c Precision Medicine Center, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China;d Center for Molecular Diagnosis and Precision Medicine, Department of Clinical Laboratory, The First Affiliated Hospital of Nanchang University, Nanchang, ChinaCorrespondence[email protected]
View further author information
&
Rongfu Tua Department of Cancer Precision Medicine, the MED-X Institute, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4484-3176View further author information
ORCID Icon show all
Article: 2237200 | Received 03 Feb 2023, Accepted 12 Jul 2023, Published online: 18 Jul 2023

References

  • Zhu J, Thompson CB. Metabolic regulation of cell growth and proliferation. Nat Rev Mol Cell Biol. 2019;20(7):436–8. doi:10.1038/s41580-019-0123-5.
  • Aird KM, Zhang R. Nucleotide metabolism, oncogene-induced senescence and cancer. Cancer Lett. 2015;356(2):204–210. doi:10.1016/j.canlet.2014.01.017.
  • Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27(1):441–464. doi:10.1146/annurev-cellbio-092910-154237.
  • Dong Y, Tu R, Liu H, Qing G. Regulation of cancer cell metabolism: oncogenic MYC in the driver’s seat. Curr Signal Transduct Ther. 2020;5(1):124. doi:10.1038/s41392-020-00235-2.
  • Lane AN, Fan TW. Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res. 2015;43(4):2466–2485. doi:10.1093/nar/gkv047.
  • Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362(23):2202–2211. doi:10.1056/NEJMra0804577.
  • Huang M, Weiss WA. Neuroblastoma and MYCN. Cold Spring Harb Perspect Med. 2013;3(10):a014415–a014415. doi:10.1101/cshperspect.a014415.
  • Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F, Schleiermacher G, Park JR, et al. Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol. 2015;33(27):3008–3017. doi:10.1200/JCO.2014.59.4648.
  • Tu R, Kang W, Yang M, Wang L, Bao Q, Chen Z, Dong Y, Wang J, Jiang J, Liu H, et al. USP29 coordinates MYC and HIF1α stabilization to promote tumor metabolism and progression. Oncogene. 2021;40(46):6417–6429. doi:10.1038/s41388-021-02031-w.
  • Gao R, Buechel D, Kalathur RKR, Morini MF, Coto-Llerena M, Ercan C, Piscuoglio S, Chen Q, Blumer T, Wang X, et al. USP29-mediated HIF1α stabilization is associated with sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis. Oncogenesis. 2021;10(7):52. doi:10.1038/s41389-021-00338-7.
  • Liu J, Chung H-J, Vogt M, Jin Y, Malide D, He L, Dundr M, Levens D. JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress. Embo J. 2011;30(5):846–858. doi:10.1038/emboj.2011.11.
  • Martin Y, Cabrera E, Amoedo H, Hernández-Pérez S, Domínguez-Kelly R, Freire R. USP29 controls the stability of checkpoint adaptor Claspin by deubiquitination. Oncogene. 2015;34(8):1058–1063. doi:10.1038/onc.2014.38.
  • Chandrasekaran AP, Woo SH, Sarodaya N, Rhie BH, Tyagi A, Das S, Suresh B, Ko NR, Oh SJ, Kim K-S, et al. Ubiquitin-specific protease 29 regulates Cdc25A-Mediated tumorigenesis. Int J Mol Sci. 2021;22(11):5766. doi:10.3390/ijms22115766.
  • Li J, Yang J, Chen Z, Liu L, Wang H, Deng Q, Chen Y, Que Y, Fu Z. Promotive role of USP29-mediated deubiquitination in malignant proliferation of colorectal cancer cells via the KIAA1429/SOX8 axis. Bosn J of Basic Med Sci. 2022. doi:10.17305/bjbms.2022.7930.
  • Qian W, Li Q, Wu X, Li W, Li Q, Zhang J, Li M, Zhang D, Zhao H, Zou X, et al. Deubiquitinase USP29 promotes gastric cancer cell migration by cooperating with phosphatase SCP1 to stabilize Snail protein. Oncogene. 2020;39(44):6802–6815. doi:10.1038/s41388-020-01471-0.
  • Wu Y, Zhang Y, Wang D, Zhang Y, Zhang J, Zhang Y, Xu L, Wang T, Wang S, Zhang Q, et al. USP29 enhances chemotherapy-induced stemness in non-small cell lung cancer via stabilizing Snail1 in response to oxidative stress. Cell Death Disease. 2020;11(9):796. doi:10.1038/s41419-020-03008-5.
  • Hu J, Wang T, Xu J, Wu S, Wang L, Su H, Jiang J, Yue M, Wang J, Wang D, et al. WEE1 inhibition induces glutamine addiction in T-cell acute lymphoblastic leukemia. Haematologica. 2021;106(7):1816–1827. doi:10.3324/haematol.2019.231126.
  • Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102.
  • Pareek V, Pedley AM, Benkovic SJ. Human de novo purine biosynthesis. Crit Rev Biochem Mol Biol. 2021;56(1):1–16. doi:10.1080/10409238.2020.1832438.
  • Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23(1):27–47. doi:10.1016/j.cmet.2015.12.006.
  • Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer. 2008;8(9):705–713. doi:10.1038/nrc2468.
  • Tu R, Ma J, Zhang P, Kang Y, Xiong X, Zhu J, Li M, Zhang C. The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism. Cancer Cell Int. 2022;22(1):130. doi:10.1186/s12935-022-02524-y.
  • Vander Heiden MG. Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov. 2011;10(9):671–684. doi:10.1038/nrd3504.
  • D’Arcy P, Wang X, Linder S. Deubiquitinase inhibition as a cancer therapeutic strategy. Pharmacology & Therapeutics. 2015;147:32–54. doi:10.1016/j.pharmthera.2014.11.002.
  • Harrigan JA, Jacq X, Martin NM, Jackson SP. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov. 2018;17(1):57–78. doi:10.1038/nrd.2017.152.
  • Chandrasekaran AP, Suresh B, Sarodaya N, Ko N-R, Oh S-J, Kim K-S, Ramakrishna S. Ubiquitin specific protease 29 functions as an oncogene promoting tumorigenesis in colorectal carcinoma. Cancers Basel. 2021;13(11):2706. doi:10.3390/cancers13112706.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.